Canopy Growth Corp (CGC)
9.045
-0.82
(-8.27%)
USD |
NASDAQ |
May 10, 16:00
9.07
+0.02
(+0.28%)
After-Hours: 18:01
Canopy Growth Research and Development Expense (Quarterly): 0.963M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.963M |
| September 30, 2023 | 0.8234M |
| June 30, 2023 | 1.005M |
| March 31, 2023 | 3.229M |
| December 31, 2022 | 3.613M |
| September 30, 2022 | 4.204M |
| June 30, 2022 | 5.441M |
| March 31, 2022 | 6.887M |
| December 31, 2021 | 5.165M |
| September 30, 2021 | 6.958M |
| June 30, 2021 | 6.792M |
| March 31, 2021 | 12.47M |
| December 31, 2020 | 10.71M |
| September 30, 2020 | 10.63M |
| June 30, 2020 | 9.853M |
| March 31, 2020 | 15.35M |
| December 31, 2019 | 15.76M |
| September 30, 2019 | 9.034M |
| June 30, 2019 | 6.344M |
| Date | Value |
|---|---|
| March 31, 2019 | 5.469M |
| December 31, 2018 | 3.981M |
| September 30, 2018 | 1.487M |
| June 30, 2018 | 0.5858M |
| March 31, 2018 | 0.9018M |
| December 31, 2017 | 0.2256M |
| September 30, 2017 | 0.3941M |
| June 30, 2017 | 0.0989M |
| March 31, 2017 | -0.404M |
| December 31, 2016 | 0.3289M |
| September 30, 2016 | 0.3857M |
| June 30, 2016 | 0.3127M |
| March 31, 2016 | 0.204M |
| December 31, 2015 | 0.1438M |
| September 30, 2015 | 0.1605M |
| June 30, 2015 | 0.0312M |
| December 31, 2014 | 0.0362M |
| September 30, 2014 | 0.0533M |
| June 30, 2014 | 0.0554M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.8234M
Minimum
Sep 2023
15.76M
Maximum
Dec 2019
7.117M
Average
6.792M
Median
Jun 2021
Research and Development Expense (Quarterly) Benchmarks
| Tilray Brands Inc | 0.106M |
| Clever Leaves Holdings Inc | 0.233M |
| Flora Growth Corp | 0.025M |
| Acasti Pharma Inc | 1.443M |
| Aurinia Pharmaceuticals Inc | 10.23M |